What makes a country competitive for a clinical research?
India | Opinion | By BioSpectrum Bureau | 2 Comment | 05 Sep, 2013
Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...Read more
Dr. Reddy's intends to buy Dutch firm
India | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2012
Hyderabad: Dr. Reddy's Laboratories, together with its subsidiaries, announced the intended public offer to acquire the...Read more
Sudha Rao: Your decisions are milestones of your life's journey
India | Influencers | By BioSpectrum Bureau | 1 Comment | 08 Mar, 2013
I completed my graduation and post graduation from the University of Mysore. My first job, after my post doctoral studie...Read more
Sigma-Tau wins coveted MMV anti-malarial award
India | News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
New Delhi: The project team for Eurartesim, dihydroartemisinin-piperaquine (DHA-PQP), the first novel chemical entity d...Read more
Orchid exits 10-year-old JV in China due to competition
India | News | By BioSpectrum Bureau | 0 Comment | 15 Nov, 2012
Chennai: Chennai-based global pharma major, Orchid Chemicals and Pharmaceuticals has exited its 50:50 manufacturing joi...Read more
Novel therapeutic from CSIR gets go ahead for trial
India | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
New Delhi: The Drugs Controller General of India (DCGI) has cleared the clot-specific streptokinase (CSSK), a pioneering...Read more
Cipla appoints Frank Pieters as head of European region
India | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012
Mumbai: Cipla, one of India's leading pharmaceutical companies announced the appointment of Mr Frank Pieters as the head...Read more
New Japanese encephalitis vaccine in India
India | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2012
Bangalore: Intercell has partnered with Biological E to launch JEEV, a vaccine designed to protect children and adults ...Read more
What are the hurdles before stem cell research?
India | Analysis | By Piyusha Chatterjee | 2 Comment | 31 Jan, 2013
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...Read more
Existing TB treatments take too long to be effective'
India | News | By Rahul Koul Koul | 0 Comment | 12 Mar, 2012
Microbial geneticist Dr Gyanu Lamichhane of the Johns Hopkins Center for Tuberculosis Research is one of the foremost au...Read more
Indian Drug Controller: People mistrusted the system
India | Influencers | By Rahul Koul Koul | 1 Comment | 17 Apr, 2013
India's drug regulator, the Central Drug Standard Control Organization (CDSCO), had in 2012 received World Health Organi...Read more
India revives public sector units in vaccines
India | Analysis | By Rahul Koul Koul | 2 Comment | 04 Jun, 2012
Keeping health security of the country in mind and the success of the Universal Immunization Programme (UIP), India has ...Read more
Mylan, Teva to setup plants worth $235 mn at Indore in India
India | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013
Singapore: Global pharmaceutical giants Mylan and Teva are planning to launch manufacturing units in the city of Indore,...Read more
Pakistan bans import of APIs from India
India | News | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013
New Delhi: The state government of Punjab in Pakistan has instructed pharmaceutical companies to not use raw materials t...Read more
Indian state of AP signs MoU with Korean techpark
India | News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2013
Hyderabad: The state undertaking of Andhra Pradesh Industrial Infrastructure Development, India, signed a memorandum of ...Read more
Indian firms get FDA approval for 110 generic drugs
India | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: India pharmaceutical companies have yet again emerged as the biggest overseas sources of medicines sold in th...Read more
Ideal Cures to launch Instanute DR at Geneva event
India | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Indian pharmaceutical company Ideal Cures will launch its newly developed delayed release delivery system, In...Read more
Wockhardt's regulatory unit gets new head
India | News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2014
Singapore: After facing a wave of troubles from the US drug regulatory body through the last 12 months, leading Indian d...Read more